Skip to content

Clinical trials

Completed Phase 1 Mesothelioma, Malignant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Phase: Phase 1 Status: Completed Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20033
20064
20072
20081
20092
20101
20112
20121
20142
20152
20172
20181
20191
20202
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center5
National Cancer Institute (NCI)5
Memorial Sloan Kettering Cancer Center3
University of Pennsylvania3
Abramson Cancer Center at Penn Medicine2
Erasmus Medical Center2
National Institutes of Health Clinical Center (CC)2
Roswell Park Cancer Institute2
Aduro Biotech, Inc.1
Asbestos Diseases Research Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant39
Carcinoma, Non-Small-Cell Lung16
Lung Neoplasms10
Mesothelioma8
Pancreatic Neoplasms8
Breast Neoplasms6
Carcinoma, Ovarian Epithelial6
Fallopian Tube Neoplasms6
Neoplasms6
Uterine Cervical Neoplasms6

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.